Poseida Therapeutics Inc (PSTX)
2.54
+0.07
(+2.83%)
USD |
NASDAQ |
Nov 04, 16:00
2.535
0.00 (0.00%)
After-Hours: 20:00
Poseida Therapeutics Shareholders Equity (Quarterly): 60.82M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 60.82M |
| March 31, 2024 | 84.59M |
| December 31, 2023 | 103.70M |
| September 30, 2023 | 123.66M |
| June 30, 2023 | 135.30M |
| March 31, 2023 | 157.56M |
| December 31, 2022 | 187.60M |
| September 30, 2022 | 216.31M |
| June 30, 2022 | 65.80M |
| March 31, 2022 | 103.70M |
| Date | Value |
|---|---|
| December 31, 2021 | 156.21M |
| September 30, 2021 | 150.16M |
| June 30, 2021 | 186.58M |
| March 31, 2021 | 227.49M |
| December 31, 2020 | 261.97M |
| September 30, 2020 | 295.84M |
| June 30, 2020 | -205.30M |
| March 31, 2020 | 47.04M |
| December 31, 2019 | -149.51M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-205.30M
Minimum
Jun 2020
295.84M
Maximum
Sep 2020
116.29M
Average
135.30M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| MaxCyte Inc | 221.26M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 298.69M |
| Total Liabilities (Quarterly) | 237.87M |
| Debt to Equity Ratio | 0.9668 |
| Current Ratio | 2.483 |
| Net Debt Paydown Yield | -0.03% |